Clinical Trials · NCT00311766
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Enrollment
- 30
- Start date
- Feb 2006
- Locations
- See registry
- Primary endpoint
- Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)